Cover Image
Market Research Report
Product code 

Electrocardiograph (ECG) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Published: | Mordor Intelligence Pvt Ltd | 125 Pages | Delivery time: 2-3 business days


Back to Top
Electrocardiograph (ECG) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Published: January 17, 2022
Mordor Intelligence Pvt Ltd
Content info: 125 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

Increase in prevalence of heart diseases worldwide is the primary factor driving the electrocardiograph (ECG) market globally. According to the WHO, cardiovascular disease is one of the leading cause of death worldwide. It is estimated that cardiovascular diseases (CVDs) take the lives of 17.9 million people every year, 31% of all global deaths. In addition, an increase in demand for the invasive techniques and lifestyle changes bolstering the electrocardiograph (ECG) market. Furthermore, technological advancements and growing accessibility to the advanced treatments are expected to boost the electrocardiograph (ECG) market.

In many of the developing countries, owing to the cost-effective factor, physicians are forced to use traditional ECG devices instead of the latest high-end devices. Hence, high cost for buying and maintaining, and lack of technical skills are hindering the growth of the market in developing regions. In developed regions, the new sales is almost equal to the replacement rate because of already well- established infrastructure.

Key Market Trends

Holter ECG Systems will continue to demonstrate strong growth in the market

The Holter ECG monitors have witnessed significant growth rate during the forecast period. The Holter ECG monitors were considered as the most common type of ambulatory monitoring of ECG which has led to the high utilization of Holter ECG monitors for identification of many cardiovascular diseases. Moreover, the introduction of wireless Holter monitors attributed to generating significant market share in ECG market globally.

The penetration of wireless systems in point of care boosted the adoption of home care setting which further propelled the growth of the global ECG market.

North America to dominate the growth of Electrocardiograph (ECG) market

North American holds the leading position in electrocardiograph (ECG) market owing to an increase in the patient pool of cardiovascular and cancer diseases in the US and Canada. As per the report from the American Heart Association on heart disease and stroke, in 2017, over approximately 800,000 deaths due to cardiovascular disease.

The Asia Pacific is also expected to witness significant growth due to the increasing prevalence of the cardiovascular disease, growing technological advancements, rapid growth in the economy and favourable initiatives by the government.

Latin America is expected to show considerable growth due to lifestyles changes and the increasing prevalence of the cardiovascular disease. According to World heart federation, Latin America holds a high risk of abdominal obesity, high blood cholesterol, hypertension etc. In 2015, According to the study, about 1.6 million deaths were recording in Latin America and the Caribbean because of cardiovascular diseases. The universal healthcare scheme in Brazil along with rising government focus for improving public health is fueling the market growth.

Competitive Landscape

Electrocardiograph (ECG) is a highly fragmented market with the presence of many prominent players. Companies are focusing on the major collaborations, mergers and acquisitions in order to enhance their market share. Market players are also focusing on R&D to improve product quality and minimize manufacturing costs, developing safer devices to improve patient compliance and safety.

For instance,

  • In 2018, Qardio, Inc., has received the approval from Australia's Therapeutic Goods Administration (TGA) for QardioCore, its revolutionary ECG monitor.
  • In 2019, Omron Healthcare Launched its First Wearable Blood Pressure Monitor, Previews Breakthrough Monitor with EKG and New Digital Health Services.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Product Code: 52450



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Cases of Cardiovascular Diseases
    • 4.2.2 Rising Aging Population Has High Risk of Cardiac Disease
    • 4.2.3 Increasing Usage of Remote Monitoring Device
    • 4.2.4 Rapid Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Expensive Instrument and Maintenance
    • 4.3.2 Complex Reimbursement Policies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product
    • 5.1.1 Rest ECG Systems
    • 5.1.2 Stress ECG Systems
    • 5.1.3 Holter ECG Systems
    • 5.1.4 Event Recorders
    • 5.1.5 Others
  • 5.2 By Technology
    • 5.2.1 Portable ECG Systems
    • 5.2.2 Wireless ECG Systems
  • 5.3 By Lead Type
    • 5.3.1 Single Lead ECG
    • 5.3.2 3-6 Lead ECG
    • 5.3.3 12 Lead ECG
  • 5.4 By End User
    • 5.4.1 Home-Based Users
    • 5.4.2 Hospitals
    • 5.4.3 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
      • United States
      • Canada
      • Mexico
    • 5.5.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.5.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.5.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 GE Healthcare
    • 6.1.2 Koninklinje Philips NV
    • 6.1.3 Nihon Kohden Corporation
    • 6.1.4 Schiller AG
    • 6.1.5 OSI Systems Inc. (Spacelabs Healthcare)
    • 6.1.6 AliveCor
    • 6.1.7 Mindray Medical International Limited
    • 6.1.8 Medtronic PLC
    • 6.1.9 Hill-Rom Holdings Inc. (Welch Allyn)